We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Characterization and <i>ex vivo</i> evaluation of curcumin nanoethosomes for melanoma treatment.
- Authors
Nair, Rajesh Sreedharan; Billa, Nashiru; Mooi, Lim Yang; Morris, Andrew P
- Abstract
This study aimed at developing curcumin nanoethosomes (Cur-Ets) with superior skin permeation intended for melanoma treatment. Although curcumin is active against many types of skin cancers, a suitable topical formulation is still lacking due to its hydrophobicity and poor skin permeation. The formulation was characterized using Scanning Transmission Electron Microscopy (STEM), atomic force microscopy (AFM), ATR-FTIR, DSC and XRD. In vitro skin permeation was carried out using human skin, and the cytotoxicity of the formulation was evaluated on human melanoma cells (SK-MEL28). The vesicle size and zeta potential of the Cur-Ets were determined as 67 ± 1.6 nm and -87.3 ± 3.3 mV, respectively. STEM and AFM analysis further support the size and morphology of the formulation. Curcumin's compatibility with formulation additives was confirmed by ATR-FTIR analysis. In addition, DSC and XRD analyses showed successful drug encapsulation in nanoethosomes. The drug encapsulation efficiency was determined as 87 ± 0.9%. The skin permeation of curcumin from Cur-Ets showed a superior flux (0.14 ± 0.03 µg cm -2 h -1 ) compared to the control ( p < 0.05). Cytotoxicity of the formulation demonstrated a time-dependent and concentration-dependent antiproliferative activity against melanoma cells. The developed Cur-Ets is suggested as a promising topical formulation for melanoma treatment.
- Publication
Pharmaceutical development and technology, 2022, Vol 27, Issue 1, p72
- ISSN
1097-9867
- Publication type
Journal Article
- DOI
10.1080/10837450.2021.2023568